NCT04202731

Brief Summary

Assessing sleep and circadian health in severely obese adolescents undergoing bariatric surgery and examine relation to health outcomes including insulin sensitivity and percent weight loss to date at 1-year and evaluate the impact of sleep extension on health outcomes in this population.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2019

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

December 16, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 18, 2019

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 14, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 14, 2023

Completed
Last Updated

July 27, 2023

Status Verified

July 1, 2023

Enrollment Period

3.6 years

First QC Date

December 16, 2019

Last Update Submit

July 24, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sleep duration

    Total sleep time at night in hours

    1 week

Study Arms (1)

Sleep Extension

EXPERIMENTAL

Participants will be asked to extend their time in bed with the goal of improving the total time they sleep each night.

Behavioral: PBS Study

Interventions

PBS StudyBEHAVIORAL

Sleep extension intervention

Sleep Extension

Eligibility Criteria

Age12 Years - 21 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • ages 12-21 years
  • attending high school or middle school (peak period for insufficient and delayed sleep)
  • completion of bariatric surgery procedure (i.e., vertical sleeve gastrectomy) within the past 2 years but not less than 6 months prior to study participation
  • All must also be Tanner Stage 5

You may not qualify if:

  • regular use of medications affecting sleep (e.g., stimulants, atypical antipsychotics, melatonin or other sleep aids) or insulin resistance (systemic steroids, other oral diabetes medications)
  • HbA1c ≥6.5%
  • intelligence quotient (IQ) \<70 or severe mental illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital Colorado

Aurora, Colorado, 80045, United States

Location

Study Officials

  • Jill L Kaar, PhD

    University of Colorado Denver | Anschutz

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 16, 2019

First Posted

December 18, 2019

Study Start

November 20, 2019

Primary Completion

July 14, 2023

Study Completion

July 14, 2023

Last Updated

July 27, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations